Hepatitis C in patients co-infected with human immunodeficiency virus. A review and experience of a Brazilian ambulatory (Q36119738)

12 August 2017

1 reference

title

Hepatitis C in patients co-infected with human immunodeficiency virus. A review and experience of a Brazilian ambulatory (English)

1 reference

12 August 2017

author name string

Maria Cássia Jacintho Mendes-Corrêa

series ordinal

1 reference

12 August 2017

Antonio Alci Barone

series ordinal

1 reference

12 August 2017

publication date

1 March 2005

1 reference

Revista do Instituto de Medicina Tropical de São Paulo

12 August 2017

1 reference

inferred from page(s)

published in

1 reference

12 August 2017

1 reference

12 August 2017

1 reference

12 August 2017

page(s)

59-64

1 reference

HIV and hepatitis C coinfection within the CAESAR study

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46652005000200001

Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46652005000200001

Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46652005000200001

Patients co-infected with human immunodeficiency virus and hepatitis C virus demonstrate higher levels of hepatic HCV RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46652005000200001

Recombinant interferon-alpha for chronic hepatitis C in patients positive for antibody to human immunodeficiency virus. Comité des Anti-Viraux

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46652005000200001

Update on chronic hepatitis C in HIV/HCV-coinfected patients: viral interactions and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46652005000200001

Intrafamilial transmission of hepatitis C virus: the important role of inapparent transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46652005000200001

Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46652005000200001

Hepatitis C virus load is associated with human immunodeficiency virus type 1 disease progression in hemophiliacs

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46652005000200001

Mortality from liver cancer and liver disease in haemophilic men and boys in UK given blood products contaminated with hepatitis C. UK Haemophilia Centre Directors' Organisation

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46652005000200001

Coinfection of hepatitis C virus with human immunodeficiency virus and progression to AIDS. Italian Seroconversion Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46652005000200001

Heterosexual co-transmission of hepatitis C virus (HCV) and human immunodeficiency virus (HIV).

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46652005000200001

Prevalence of hepatitis viruses in an anti-human immunodeficiency virus-positive population from Argentina. A multicentre study

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46652005000200001

Heterosexual transmission of hepatitis C, hepatitis B, and HIV-1 in a sample of inner city women

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46652005000200001

Hepatitis C virus viremia in HIV-infected individuals with negative HCV antibody tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46652005000200001

Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46652005000200001

Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46652005000200001

Long-term efficacy of combination therapy with interferon-alpha 2b and ribavirin for severe chronic hepatitis C in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46652005000200001

Hepatitis C virus in lymphoid cells of patients coinfected with human immunodeficiency virus type 1: evidence of active replication in monocytes/macrophages and lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46652005000200001

A randomized, double-blind trial comparing pegylated interferon alfa-2b to interferon alfa-2b as initial treatment for chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46652005000200001

Hepatitis C virus infection among sexually promiscuous groups and the heterosexual partners of hepatitis C virus infected index cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46652005000200001

Mortality due to liver failure and impact on survival of hepatitis virus infections in HIV-infected patients receiving potent antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46652005000200001

Increasing impact of chronic viral hepatitis on hospital admissions and mortality among HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46652005000200001

Prevalence of hepatitis B and C in the sera of patients with HIV infection in São Paulo, Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46652005000200001

Chronic hepatitis C in HIV infection: feasibility and sustained efficacy of therapy with interferon alfa-2b and tribavirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46652005000200001

Randomised trial of effects of interferon-alpha on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46652005000200001

Viral hepatitis in patients infected with human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46652005000200001

Interferon plus ribavirin in HIV-infected patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46652005000200001

Pegylated IFN-alpha2b plus ribavirin as therapy for chronic hepatitis C in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46652005000200001

Liver biopsy findings in 501 patients infected with human immunodeficiency virus (HIV).

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46652005000200001

Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46652005000200001

Sexual transmission of hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46652005000200001

The association between hepatitis C virus genotype and human immunodeficiency virus disease progression in a cohort of hemophilic men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46652005000200001

Hepatitis C virus coinfection in a cohort of HIV-infected individuals from Santos, Brazil: seroprevalence and associated factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46652005000200001

Care of patients with chronic hepatitis C and HIV co-infection: recommendations from the HIV-HCV International Panel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46652005000200001

Consensus conference on chronic viral hepatitis and HIV infection: updated Spanish recommendations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46652005000200001

Care of patients with hepatitis C and HIV co-infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46652005000200001

Hepatitis C virus (HCV) relapses after anti-HCV therapy are more frequent in HIV-infected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46652005000200001

Heterosexual transmission of hepatitis C virus and the possible role of coexistent human immunodeficiency virus infection in the index case. A multicentre study of 423 pairings

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46652005000200001

Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46652005000200001

Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46652005000200001

Hepatitis C and progression of HIV disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46652005000200001

Hepatitis C in the HIV-Infected Person

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46652005000200001

The progression of HCV-associated liver disease in a cohort of haemophilic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46652005000200001

Sexual transmission of hepatitis C virus among patients attending sexually transmitted diseases clinics in Baltimore--an analysis of 309 sex partnerships

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46652005000200001

The natural history of hepatitis C virus infection: host, viral, and environmental factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46652005000200001

Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46652005000200001

Persistence of viremia and the importance of long-term follow-up after acute hepatitis C infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46652005000200001

Peginterferon alfa-2a in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46652005000200001

Reciprocal interactions between human immunodeficiency virus and hepatitis C virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46652005000200001

Seroprevalence of HIV, HCV and syphilis in Brazilian prisoners: preponderance of parenteral transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46652005000200001

10.1590/S0036-46652005000200001

21 January 2018

Identifiers

DOI

1 reference

12 August 2017

1 reference